ArticleFrontiers in surgery2026
Acupoint glucocorticoid injection combined with focused ultrasound for granulomatous lobular mastitis: a retrospective study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Granulomatous lobular mastitis (GLM) is a chronic benign inflammatory breast disease with significant treatment challenges. Traditional therapies often result in high recurrence rates and cosmetic concerns. Objective: To evaluate the efficacy and safety of combining acupoint glucocorticoid injection with focused ultrasound therapy for GLM treatment. Methods: This retrospective study analyzed 186 patients with histologically confirmed GLM treated between July 2021 and December 2024. Patients were divided into three groups: acupoint injection plus focused ultrasound (AI + FUS, Results: The AI + FUS group demonstrated significantly higher complete response rates (92.2%) compared to CIS (75.4%) and OCS (68.9%) groups ( Conclusion: Combined acupoint glucocorticoid injection with focused ultrasound may represent a useful therapeutic option for GLM, with potential benefits in efficacy, recurrence, cosmetic outcomes, and systemic side effects compared to conventional treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.